Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (Clinical Trials Optional)
This grant supports CTSA Program Hubs in developing innovative research platforms and resources to address critical gaps in clinical and translational science for future widespread adoption.
Funder: National Institutes of Health
Due Dates (Anticipated): September 2026 (Full application deadline, projected)
Funding Amounts: Not specified; award size and duration vary by project. No cost sharing required.
Summary: Supports the development and demonstration of innovative capabilities or resources to address critical gaps in clinical and translational science at CTSA Program Hubs.
Key Information: Forecasted opportunity; only primary UM1 CTSA program hub organizations are eligible to apply.
Description
This program provides funding for High Impact Specialized Innovation Programs (SIPs) to advance unique capabilities, research platforms, or resources at Clinical and Translational Science Award (CTSA) Program Hubs. The goal is to address urgent or persistent barriers in clinical and translational science, enabling rapid progress and future adoption or dissemination of successful approaches across the CTSA network. Applications are limited to eligible CTSA UM1 hub institutions, and the initiative is designed as a limited competition among those hubs.
